NCT06471010

Brief Summary

This study aims to explore the feasibility, acceptability, and effectiveness of a new blended psychotherapeutic treatment program based on Dynamic Interpersonal Therapy (B-DIT) for adult clients with personality pathology. Blended interventions have the potential to improve treatment accessibility and cost-effectiveness for individuals with personality pathology and promote a sense of agency and ownership among clients regarding their treatment as compared to traditional Face-to-Face (FTF) approaches. This may improve treatment outcome and recovery. The B-DIT intervention, developed collaboratively by Dutch mental health care institute De Viersprong and OnlinePsyHulp, integrates FTF therapy and online modules into a cohesive treatment program. The program spans three phases: an individual phase lasting approximately two months, followed by a four-month group phase, and concluding with a four-month booster phase to reinforce positive changes. Face-to-face therapy sessions and online treatment modules are utilized alternately and complementarily throughout all treatment phases. The primary study aims are (1) to monitor and evaluate the feasibility of B-DIT; which includes evaluating client satisfaction, treatment drop-out rates, user parameters related to online modules, and an interview-based qualitative analysis of therapists' and clients' experiences; and (2) to gather initial effectiveness data based on Routine Outcome Monitoring (ROM) measurements, complemented by a Single Case Experimental Design (SCED). The research questions are as follows:

  1. 1.How acceptable is the blended treatment program, B-DIT, for adult clients with personality pathology and their therapists?
  2. 2.What is the effectiveness of B-DIT for adult clients with personality pathology in terms of progress in reducing symptom burden, overall functioning, and personality functioning, including changes in process measures such as mentalizing ability, epistemic trust, and agency?
  3. 3.Exploratively, the effects on these process and outcome measures across treatment phases will be compared to ascertain if observed changes align with the presumed working mechanisms of the intervention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
19mo left

Started Jun 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Jun 2024Dec 2027

First Submitted

Initial submission to the registry

June 12, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

June 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

June 12, 2024

Last Update Submit

September 4, 2025

Conditions

Keywords

Blended treatmentE-healthPsychotherapyPersonality disorderPersonality pathologyTreatment accessibility

Outcome Measures

Primary Outcomes (5)

  • Personality functioning- Severity Indices of Personality Functioning

    Personality functioning- Severity Indices of Personality Functioning (SIPP-60): a 60-item self-report ROM questionnaire Administered as part of Routine Outcome Monitoring at start of intervention and subsequently every treatment evaluation (at 12, 20 and 30 weeks after start of the intervention); at the end of treatment; and at two follow-up timepoints after the end of treatment (6 and 12 months follow-up)

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Personality functioning- Level of Personality Functioning

    Personality functioning - Level of Personality Functioning Brief-Form 2.0 (LBFS-BF-2.0): a 12-item self-report ROM questionnaire. Administered as part of Routine Outcome Monitoring at start of intervention and subsequently every treatment evaluation (at 12, 20 and 30 weeks after start of the intervention); at the end of treatment; and at two follow-up timepoints after the end of treatment (6 and 12 months follow-up).

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Symptom distress

    Brief Symptom Inventory (BSI): a 53-item self-report ROM questionnaire. Administered as part of Routine Outcome Monitoring at start of intervention and subsequently every treatment evaluation (at 12, 20 and 30 weeks after start of the intervention); at the end of treatment; and at two follow-up timepoints after the end of treatment (6 and 12 months follow-up)

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Overall functioning

    Outcome Rating Scale (ORS): a 4-item self-report questionnaire. Outcome measures of the Single Case Experimental Design are assessed using a composite questionnaire that is delivered to participants repeatedly in varying frequencies depending on the phase of treatment and respective phase of the SCED. During: * Phase A: weekly during the baseline waiting period with a minimum of three weeks. * Phase B: bi-weekly during the first intervention phase of 10 weeks individual treatment and second intervention phase of 20 weeks group treatment * Phase C: monthly during the third intervention phase (booster phase) of 16 weeks * Phase D: two-monthly during the follow-up phase of 12 months

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Usability of the online portal

    System Usability Scale (SUS): a 10-item self-report questionnaire

    End of treatment (end of phase C)

Secondary Outcomes (5)

  • Agency

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Epistemic Trust

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Reflective Functioning

    From baseline, throughout the intervention, to 12 months after end of treatment

  • Treatment expectations

    Baseline - after indication for treatment; End of treatment (end of phase C)

  • Experiences of clients and clinicians

    End of phase C (booster phase)

Study Arms (1)

B-DIT

Other: Blended Dynamic Interpersonal Therapy (B-DIT)

Interventions

The B-DIT intervention, developed collaboratively by Dutch mental health care institute De Viersprong and OnlinePsyHulp (http://www.onlinepsyhulp.be), integrates FTF therapy and online modules into a cohesive treatment program for clients with personality pathology. Both FTF and online treatment components are anchored in the Dynamic Interpersonal Therapy (DIT) framework (Lemma et al., 2011).The program spans three phases: an individual phase lasting approximately two months, followed by a five-month group phase, concluding with a four-month booster phase to reinforce positive changes. Face-to-face therapy sessions and online treatment modules are utilized alternately and complementarily throughout all treatment phases. Both verbal psychotherapy and art therapy are offered as treatment modalities in the face-to-face treatment sessions. The program is implemented by a multidisciplinary team.

B-DIT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Clients referred to De Viersprong are eligible for B-DIT when they exhibit mild to moderately severe impairments in personality functioning (including both cluster B, C, or a mixed presentation within unspecified personality disorder). Clients typically present with persistent problems in specific areas of their functioning, and typically have had previous, unsuccessful treatments. Adequate functioning in at least one domain of life (such as family, work, other societal roles) should be ensured, which allows for the generalization of treatment gains during and after the relatively short-term/ low intensity intervention. All patients that are referred to B-DIT at de Viersprong are eligible for the study.

You may qualify if:

  • years of age or older
  • mild to moderately severe impairments in personality functioning, including both cluster B and cluster C personality problems as well as a mixed presentation within unspecified personality disorder.

You may not qualify if:

  • insufficient proficiency in the Dutch language
  • no permanent place of residence
  • intellectual disability (IQ \< 80)
  • organic brain disorder
  • autism spectrum disorders
  • schizophrenia or schizophreniform disorder
  • (untreated) eating disorder, extreme obesity, or a BMI \< 17.5
  • (untreated) addiction.
  • acute risk of crisis requiring stabilizing/crisis interventions
  • Severe PTSD or the severe range of personality problems (structural: low-level borderline organization).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

De Viersprong

Halsteren, North Brabant, 4660AA, Netherlands

Location

Related Publications (1)

  • Lemma A, Target M, Fonagy P. The development of a brief psychodynamic intervention (dynamic interpersonal therapy) and its application to depression: a pilot study. Psychiatry. 2011 Spring;74(1):41-8. doi: 10.1521/psyc.2011.74.1.41.

    PMID: 21463169BACKGROUND

Related Links

MeSH Terms

Conditions

Personality Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Maaike L Smits, Dr.

    De Viersprong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2024

First Posted

June 24, 2024

Study Start

June 17, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations